Clinical Trial Update: Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating the long-term safety of udenafil in patients with pulmonary arterial hypertension has completed. The sponsor is Dong-A ST …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• udenafil (udenafil)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Pulmonary Arterial Hypertension | Phase 2, Phase 3 | Status: COMPLETED